J Fortea

532 citations

21 papers · 396 indexed · h-index 9

Impact in

Gastroenterology top 5%
- Gastrointestinal motility and disorders
- Gastroesophageal reflux and treatments
Medical Terminology top 10%

Papers in ⓘ

Gastroenterology 10
- Gastrointestinal motility and disorders 10
- Gastroesophageal reflux and treatments 2
Surgery 7
- Helicobacter pylori-related gastroenterology studies 4
- Congenital gastrointestinal and neural anomalies 2

Co-authors: M. Falqués (4 shared papers)G Zanchin (2 shared papers)Peter J. Goadsby (2 shared papers)S. Díaz-Insa (2 shared papers)Nina De Klippel (1 shared paper)G Géraud (1 shared paper)Nathalie Ivanoff (1 shared paper)Hartmut Göbel (1 shared paper)
Journals: Value in Health (6 papers)Alimentary Pharmacology & Therapeutics (1 paper)Cephalalgia (1 paper)Gut (1 paper)Therapeutics and Clinical Risk Management (1 paper)
Partner nations: Spain United States Germany

In The Last Decade

J Fortea

21 papers receiving 382 citations

Peers

Countries citing papers authored by J Fortea

Since Specialization

Citations

This map shows the geographic impact of J Fortea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Fortea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Fortea more than expected).

Fields of papers citing papers by J Fortea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Fortea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Fortea. The network helps show where J Fortea may publish in the future.

Co-authors

The 25 scholars most cited alongside J Fortea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J Fortea Line = papers co-authored together J Fortea links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan Cephalalgia ·Peter J. Goadsby, G Zanchin, G Géraud, Nina De Klippel, S. Díaz-Insa, Hartmut Göbel, Luísa Simões da Cunha, Nathalie Ivanoff, M. Falqués, J Fortea	2008	154
2	Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints Alimentary Pharmacology & Therapeutics ·Eamonn M.M. Quigley, Jan Tack, William D. Chey, Supriya Rao, J Fortea, M. Falqués, C Díaz, Steven J. Shiff, Mark G. Currie, Jeffrey M. Johnston	2012	92
3	Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden Journal of Medical Economics ·J Fortea, M. Prior	2012	25
4	The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea European Journal of Obstetrics & Gynecology and Reproductive Biology ·Heinz Letzel, Yves Mégard, Rosa Lamarca, A Raber, J Fortea	2006	20
5	The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the “Act When Mild” Study International Journal of Neuroscience ·S. Díaz-Insa, Peter J. Goadsby, G Zanchin, J Fortea, M. Falqués, Carlos Vila	2011	18
6	An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries United European Gastroenterology Journal ·Viola Andresen, Peter J. Whorwell, J Fortea, S. Auziere	2014	17
7	Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis Expert Review of Clinical Pharmacology ·A Roger, J Fortea, S. Mora, Maite Artés	2008	11
8	Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom Therapeutics and Clinical Risk Management ·A Raber, Joan Heras, Joan Costa‐Font, J Fortea, Albert Cobos	2007	9
9	Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults Clinical Therapeutics ·Rosa Antonijoan, Consuelo García‐Gea, Montserrat Puntes, J A Ruiperez Perez, Ramón Esbrí, Cristina Helena dos Reis Serra, J Fortea, M.J. Barbanoj	2007	8
10	Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis Expert Review of Pharmacoeconomics & Outcomes Research ·Albert Roger, J Fortea, Sheila Mora, Maite Artés	2008	7
11	A Comparison of Ebastine 10mg Fast-Dissolving Tablet with Oral Desloratadine and Placebo in Inhibiting the Cutaneous Reaction to??Histamine in Healthy Adults Clinical Drug Investigation ·Rosa Antonijoan, Consuelo Garc a-Gea, Montserrat Puntes, Marta Valle, Ramón Esbrí, J Fortea, M.J. Barbanoj	2007	6
12	Economic Burden and Quality of Life of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Germany: Results From The Ibis-C Study Value in Health ·Peter Layer, Viola Andresen, Sebastian Diemert, Jonathan Mackinnon, J. Bertsch, J Fortea, Jan Tack	2015	5
13	[Microbiological study of the respiratory tract in children with cystic fibrosis]. PubMed ·Carmen Muñoz‐Almagro, T Juncosa, Amadeu Gené, J Fortea, J. L. Séculi, Christian Castillo Latorre	1996	5
14	The Burden of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In France: A Comparison With The European Results From The Ibis-C Observational Study Value in Health ·Benoît Coffin, Mathieu Follet, Jonathan Mackinnon, J. Bertsch, J Fortea, Jan Tack	2015	4
15	OC-066 Economic and quality-of-life burden of moderate-to-severe irritable bowel syndrome with constipation (ibs-c) in the uk: the ibis-c study Yan Yiannakou, Maria Eugenicos, DS Sanders, Anton Emmanuel, Peter J. Whorwell, Fauzia Butt, Stephen Bridger, Naila Arebi, A.J.W. Millar, V Kaushik, M Rance, Jonathan Mackinnon, J. Bertsch, J Fortea, Jan Tack	2015	4
16	Economic And Quality-Of-Life Burden Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain: The Ibis-C Study Value in Health ·Fermín Mearin, Xavier Cortés, Jonathan Mackinnon, J. Bertsch, J Fortea, Jan Tack	2014	3
17	PAL2 ATTRIBUTES FOR PREFERENCE OF NEW FAST DISSOLVING TABLET (FDT) FORMULATION OF EBASTINE IN PATIENTS WITH ALLERGY Value in Health ·A Roger, J Fortea, Maite Artés, L Montilla	2005	3
18	Assessment of patient satisfaction with ebastine fast-dissolving tablets in patients suffering from allergic rhinitis Therapy ·Albert Roger, J Fortea, M José Plazas, Sheila Mora, Maite Artés	2009	2
19	OC-082 26-Week efficacy and safety of once-daily oral linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a European perspective Gut ·Anthony Lembo, J Fortea, C Díaz, M. Falqués, Jing Shao, Bernard J. Lavins, Harvey Schneier, JM Johnston	2012	1
20	Health Care Cost Associated To Constipation Predominant Irritable Bowel Syndrome In Spain Value in Health ·Abu Raya, C. Mercader Barrull, Montse Roset, Xavier Cortés, J Fortea	2014	1

About J Fortea

J Fortea is a scholar working on Gastroenterology, Surgery, Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 396 indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (10 papers), Allergic Rhinitis and Sensitization (5 papers), Asthma and respiratory diseases (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Dermatology and Skin Diseases (2 papers), Congenital gastrointestinal and neural anomalies (2 papers), Migraine and Headache Studies (2 papers) and Gastroesophageal reflux and treatments (2 papers). The work is most often cited by research in Gastroenterology (139 citations), Medical Terminology (4 citations), Psychiatry and Mental health (175 citations), Pathology and Forensic Medicine (112 citations) and Drug Discovery (1 citation). J Fortea has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include M. Falqués, G Zanchin, Peter J. Goadsby, S. Díaz-Insa, Nina De Klippel, G Géraud, Nathalie Ivanoff, Hartmut Göbel, Jan Tack and Jeffrey M. Johnston. Their work appears in journals such as Value in Health, Alimentary Pharmacology & Therapeutics, Cephalalgia, Gut and Therapeutics and Clinical Risk Management.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact